EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion

James Del Rosso, George Han, April Armstrong, G Michael Lewitt, Abby Jacobson

Journal of Drugs in Dermatology · 2023

DOI: 10.36849/jdd.7367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von James Del Rosso und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Psoriasis, Nicotinic Acids.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatologic AgentsPsoriasisNicotinic AcidsHumansDrug CombinationsMotivationQuality of LifeTreatment OutcomeSeverity of Illness IndexSkin CreamClobetasolEmollientsEmulsionsRetinoids

Substanzen

Drug CombinationsDermatologic AgentsClobetasolNicotinic AcidsEmollientsEmulsionshalobetasoltazaroteneRetinoids

Zitieren

APA

Del Rosso, J., Han, G., Armstrong, A., Lewitt, G. M., & Jacobson, A. (2023). Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7367

Vancouver

Del Rosso J, Han G, Armstrong A, Lewitt GM, Jacobson A. Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7367

BibTeX
@article{DelRosso2023,
  author = {Del Rosso, James and Han, George and Armstrong, April and Lewitt, G Michael and Jacobson, Abby},
  title = {Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  doi = {10.36849/jdd.7367}
}
Kostenlos starten →